首 页   本刊简介  编委会  审稿专家  在线期刊  写作规范  广告合作  联系我们
您现在的位置:首页 => 在线期刊 => 2017年 12期非酒精性脂肪性肝病 => 肝脏肿瘤 =>肝癌切除术后辅助性肝动脉化疗..
肝癌切除术后辅助性肝动脉化疗栓塞对患者生存的影响及预后相关因素分析
Effect of postoperative adjuvant transarterial chemoembolization on postoperative survival of patients with liver cancer and related influencing factors for prognosis
文章发布日期:2017年11月07日  来源:  作者:邢志祥,沈世强,秦 峰,等  点击次数:710次  下载次数:140次

调整字体大小:

(此处下载失败可以在在线预览处保存副本或者右键另存为)

【摘要】:目的探讨肝切除术后辅助性经肝动脉化疗栓塞术(TACE)对肝细胞癌(HCC)患者生存的影响,并分析影响其预后的相关因素。方法回顾性分析2007年1月-2012年12月武汉大学人民医院收治的215例HCC患者的临床资料。根据肝切除术后是否联合TACE治疗分为单纯组(95例)及联合组(120例)。单纯组采用单纯肝切除术治疗,联合组先行肝切除术,术后1个月给予TACE治疗。记录2组患者一般情况、治疗情况及相关临床指标,比较2组患者术后1、3、5年生存率及无瘤生存率。计量资料组间比较采用独立样本t检验,计数资料组间比较使用χ2检验。组间生存比较采用Kaplan-Meier生存分析,采用单因素分析及Cox多因素回归分析肝切除术后预后的影响因素。结果联合组术后1、3、5年生存率分别为96.5%、67.0%、51.0%,中位生存期为51个月;单纯组分别为84.0%、49.5%、36.5%,中位生存时间为39个月,2组生存率差异有统计学意义(χ2=5.540,P=0.018)。联合组术后1、3、5年无瘤生存率均分别为91.7%、62.5%、37.5%,单纯组分别为84.0%、42.1%、26.3%,差异有统计学意义(χ2=4.942,P=0.027)。术前AFP≥400 μg/L、TNM分期Ⅲ期、肿瘤多发、肿瘤直径>5 cm 、HBsAg阳性及发生血管侵犯是影响患者肝癌切除术后预后的独立危险因素,而TACE则是患者长期生存的保护因素。结论肝切除术后行辅助性TACE治疗可明显提高HCC患者的生存率及无瘤生存率,对提高手术疗效具有重要意义。
【Abstract】:ObjectiveTo investigate the effect of postoperative adjuvant transarterial chemoembolization (TACE) on the survival of patients with hepatocellular carcinoma (HCC), as well as influencing factors for prognosis. MethodsA retrospective analysis was performed for the clinical data of 215 HCC patients who were admitted to Renmin Hospital of Wuhan University from January 2007 to December 2012. According to whether TACE was given after hepatectomy, these patients were divided into single group with 95 patients and combination group with 120 patients. A comparative analysis was performed for the two groups. The patients in the single group were given hepatectomy alone, and those in the combination group were given hepatectomy followed by TACE at one month after surgery. General status, treatment condition, and related clinical indices were recorded for both groups, and the two groups were compared in terms of the 1-, 3-, and 5-year survival rates and disease-free survival rates after surgery. The independent samples t-test was used for comparison of continuous data between groups, and the chi-square test was used for comparison of categorical data between groups. The Kaplan-Meier method was used for comparison of survival rates between groups, and univariate analysis and Cox multivariate regression analysis were used to investigate the influencing factors for prognosis after hepatectomy. ResultsIn the combination group, the 1-, 3-, and 5-year survival rates were 96.5%, 67.0%, and 51.0%, respectively, with a median survival time of 51 months; in the single group, the 1-, 3-, and 5-year survival rates were 84.0%,49.5%, and 36.5%, respectively, with a median survival time of 39 months; there was a significant difference in survival rates between the two groups (χ2=5.540, P=0.018). The 1-, 3-, and 5-year disease-free survival rates were 91.7%, 62.5%, and 37.5%, respectively, in the combination group and 84.0%, 42.1%, and 26.3%, respectively, in the single group, and there was a significant difference between the two groups (χ2=4.942, P=0.027). Preoperative alpha-fetoprotein >400 μg/L, TNM stage III, multiple tumors, tumor diameter >5 cm, positive HBsAg, and vascular invasion were independent prognostic factors in patients after hepatectomy, while TACE was a protective factor for long-term survival of these patients. ConclusionAdjuvant TACE after hepatectomy can significantly improve the survival rate and disease-free survival rate of HCC patients and has great significance in improving surgical outcome.
【关键字】:癌,肝细胞;化学栓塞,治疗性;肝切除术;预后;危险因素
【Key words】:carcinoma,hepatocellular;chemoembolization,therapeutic;hepatectomy;prognosis;risk factors
【引证本文】: XING ZX, SHEN SQ, QIN F, et al. Effect of postoperative adjuvant transarterial chemoembolization on postoperative survival of patients with liver cancer and related influencing factors for prognosis[J]. J Clin Hepatol, 2017, 33(12): 2331-2336. (in Chinese)
邢志祥,沈世强,秦峰,等. 肝癌切除术后辅助性经肝动脉化疗栓塞术对患者生存的影响及预后相关因素分析[J].临床肝胆病杂志, 2017, 33(12): 2331-2336.

地址:长春市东民主大街519号《临床肝胆病杂志》编辑部 邮编:130061 电话:0431-88782542/3542
临床肝胆病杂志 版权所有 Copyright © 2009 - 2013 Lcgdbzz.org. All Rights Reserv 吉ICP备10000617号

吉公网安备 22010402000041号